Barbara Celona

1.4k citations
13 papers · 976 indexed · 1 hit paper · h-index 10

Impact in

    • Advanced Glycation End Products research
  • Immunology top 10%
    • Immune Response and Inflammation
    • Neutrophil, Myeloperoxidase and Oxidative Mechanisms

Papers in

    • Advanced Glycation End Products research 4
    • Diabetes and associated disorders 2
    • Neurogenetic and Muscular Disorders Research 2

Barbara Celona

13 papers receiving 965 citations

Hit Papers

HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4 2012 · 514 citations
5142012202620162021100200300400500

Peers

Barbara Celona
Comparison fields: 5 of 89
  • Clinical Biochemistry 319
  • Immunology 316
  • Neurology 71
  • Molecular Biology 497
  • Cancer Research 76
Replace Shiyong Yu with:
Shiyong Yu China
Kan Koizumi Japan
Tillman Vollbrandt Germany
Franziska vom Hagen Germany
Carole Fages Finland
Mark Ingram United States
Georgia Dalagiorgou Greece
Huaijin Guan China
Melissa N. Quinsay United States
Ye Tan China
Barbara Celona relative to Shiyong Yu China Shiyong Yu's profile →
Citations per field
00.5×3.2×
Shiyong Yu · 1×
Citations per year

Countries citing papers authored by Barbara Celona

Since Specialization
Citations

This map shows the geographic impact of Barbara Celona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Celona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Celona more than expected).

Fields of papers citing papers by Barbara Celona

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Celona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Celona. The network helps show where Barbara Celona may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Barbara Celona, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barbara Celona Line = papers co-authored together Barbara Celona links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1 20243
2 202310
3 20217
4 202133
5 202039
6 201712
7 201738
8 201470
9 201369
10
HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4
Hit paper breakdown →
2012514
11 201219
12 2011155
13 20097

About Barbara Celona

Barbara Celona is a scholar working on Clinical Biochemistry, Genetics, Neurology, Molecular Biology and Immunology, having authored 13 papers that have together received 976 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (4 papers), RNA Research and Splicing (4 papers), Amyotrophic Lateral Sclerosis Research (3 papers), Diabetes and associated disorders (2 papers), Immune Response and Inflammation (2 papers), Epigenetics and DNA Methylation (2 papers), Neurogenetic and Muscular Disorders Research (2 papers) and RNA and protein synthesis mechanisms (2 papers). The work is most often cited by research in Clinical Biochemistry (319 citations), Immunology (316 citations), Neurology (71 citations), Molecular Biology (497 citations) and Cancer Research (76 citations). Barbara Celona has collaborated with scholars based in United States, Italy and Australia. Frequent co-authors include Marco E. Bianchi, Brian L. Black, Francesco De Marchis, Mattia Pedotti, Milena Schiraldi, Angela Raucci, Mario Mellado, Mariagrazia Uguccioni, Tiziana Apuzzo and Luca Varani. Their work appears in journals such as Nature Communications, PLoS Biology, Cell Reports, Cell Transplantation and Science Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026